Ken Mulvany

Mr. Ken Mulvany is a serial entrepreneur and investor with more than 20 years of business leadership experience. He is the Founder and Chairman of BenevolentAI, a $2bn machine intelligence company with end-to-end drug development capabilities. Mr. Mulvany was previously Founder and CEO of Proximagen, a leading biotech company developing medicines for central nervous system disorders, which he sold in 2012. Mulvany sits on several advisory boards including the advisory panel to the UK Government on Artificial Intelligence and the Advisory Board for Oxford Sciences Innovations. He is a member of the All-Party Parliamentary Group on Artificial Intelligence, and formerly, the Chairman of the Trustees of the Cure Parkinson’s Trust. Mr. Mulvany is a world champion sailor and competed in the 1992 America’s Cup.
Country: UK
Visit Website